Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromatosis
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 03 Jun 2017
At a glance
- Drugs Nirogacestat (Primary)
- Indications Fibroma
- Focus Therapeutic Use
- 26 May 2017 Planned End Date changed from 30 Dec 2018 to 12 Oct 2019.
- 28 Mar 2017 Results published in the Journal of Clinical Oncology
- 18 Jan 2017 Planned End Date changed from 1 Oct 2017 to 1 Dec 2018.